

All rights reserved. Regenerative medicine is emerging as an innovative and promising approach to help treat MS, focusing on repairing nerve damage, modulating the immune response, and improving the patient’s quality of life.
Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune neurological disease that affects the central nervous system, including the brain and spinal cord. In this condition, the immune system mistakenly attacks myelin, a substance that coats and protects nerve fibers. This loss of myelin interferes with the efficient transmission of electrical impulses between neurons, resulting in a wide variety of physical, sensory, and cognitive symptoms.

Although the exact cause of MS is not fully understood, several factors appear to be involved:
Symptoms vary widely from person to person and depend on the areas of the nervous system affected. The most common include:
In some cases, symptoms appear in the form of flare-ups with partial or total remissions. In others, the progression is more steady.
Regenerative medicine seeks to support the body’s ability to repair damaged tissue and restore neurological function. In the context of MS, these therapies have three main objectives:
Regenerative medicine seeks to support the body’s ability to repair damaged tissue and restore neurological function. In the context of MS, these therapies have three main objectives:
Although many therapies are still in the research phase, the first results are encouraging and are marking a turning point in the way neurodegenerative diseases are addressed.

CRU mega 20 will allow a decrease in general inflammation and general wellness effects.
New technologies allow us to accelerate and act where traditional medicine cannot access.
Diamagnetotherapy is a non-invasive therapeutic method that harnesses the power of high-intensity, low-frequency magnetic fields. These fields can activate cellular mechanisms in many pathologies, significantly reducing treatment times and improving patients’ quality of life.
The diamagnetic therapy of the CTU Mega 20 acts on the intra- and extracellular matrix, activating drainage, regeneration and a strong biostimulation of the tissues.
Diamagnetotherapy, also known as ADM therapy (diamagnetic molecular acceleration), allows pharmacological cures both in localized and extended areas, with stratification of the active ingredients without using needles or electric currents, in the total absence of pain.
The mechanisms of action generated by diamagnetotherapy are summarized as follows:
Of umbilical cord origin, they will help us to reinforce the repairing action that the body itself has, cellular regeneration to fight against aging.
Regenerative medicine based on cell therapy with the use of so-called mesenchymal/stromal cells (MSCs).
Of umbilical cord mesenchymal stem cells origin that will help the stem cells in their repairing action and slow down the aging of our body.
Exosomes are secreted by the multivesicular bodies (MVBs) of cells through their fusion with the cell membrane. A tiny sac-like structure that forms inside a cell and contains some of the cellular proteins as well as portions of the cell’s DNA and RNA.
Contact an advisor here
